Robert W. Baird reiterated their neutral rating on shares of Cogent Biosciences (NASDAQ:COGT – Free Report) in a research note issued to investors on Monday morning, Marketbeat.com reports. They currently have a $8.00 target price on the technology company’s stock, down from their prior target price of $14.00. Other analysts also recently issued reports about […]
Needham & Company LLC reissued their buy rating on shares of Cogent Biosciences (NASDAQ:COGT – Free Report) in a research note published on Monday, Benzinga reports. Needham & Company LLC currently has a $18.00 price objective on the technology company’s stock. Several other research firms also recently commented on COGT. JPMorgan Chase & Co. began […]
Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) – Equities researchers at Leerink Partnrs increased their FY2024 earnings estimates for Cogent Biosciences in a note issued to investors on Monday, February 26th. Leerink Partnrs analyst A. Berens now anticipates that the technology company will post earnings per share of ($2.16) for the year, up from their […]
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by Connor Clark & Lunn Investment Management Ltd. themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Cogent Biosciences (NASDAQ:COGT – Get Free Report) issued its quarterly earnings data on Monday. The technology company reported ($0.63) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.08), MarketWatch Earnings reports. Cogent Biosciences Trading Down 0.1 % Shares of COGT stock opened at $7.49 on Wednesday. Cogent Biosciences has […]